Evidence mapPaperPMID 41227313Full record

ArticleCells2025

Reversible Upregulation of the Senescence-Associated Beta-Galactosidase Marker Induced by Cell Detachment in Cancer Cells.

Nina Semenova, Juan Sebastian Yakisich, Robyn Ascue, Anand K V Iyer, Neelam Azad

Abstract read
In one paragraph

Article in Cells, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Nina SemenovaDepartment of Pharmaceutical Sciences, School of Pharmacy, Hampton University, Hampton, VA 23668, USA.
Juan Sebastian YakisichDepartment of Pharmaceutical Sciences, School of Pharmacy, Hampton University, Hampton, VA 23668, USA.ORCID 0000-0002-8754-2667
Robyn AscueDepartment of Pharmaceutical Sciences, School of Pharmacy, Hampton University, Hampton, VA 23668, USA.ORCID 0009-0005-3659-8539
Anand K V IyerSchool of Pharmacy, Hampton University, Hampton, VA 23668, USA.
Neelam AzadThe Office of the Vice President for Research, Hampton University, Hampton, VA 23668, USA.ORCID 0000-0001-6970-5867

Funding

NIH-NIGMS GM121287
6 · The paper itself

Abstract

During metastasis, cancer cells detach from the primary tumor, and the floating cells enter the circulation and reattach in distant organs. Floating cells are highly chemoresistant to anticancer drugs, but the underlying mechanisms are poorly understood. We hypothesized that floating cells transition into a quiescent/senescent (Q/S) state. Using human lung carcinoma H460 and H23, human prostate adenocarcinoma PC3, and human breast adenocarcinoma MDA-MB-231 cells, we found (1) a progressive increase in activity of β-galactosidase (β-Gal), a marker associated with Q/S cells, (2) a transition to a non-proliferative state while growing under anchorage-independent conditions, and (3) upon reattachment, the β-Gal activity returned to the basal level and cells resumed proliferation. Similar experiments were performed in parallel with cells treated with etoposide (Eto), a well-known inductor of senescence. Eto-untreated floating cells resumed proliferation faster and showed a quicker decrease in β-Gal activity compared to Eto-induced senescent cells. We conclude that cell detachment per se triggers a reversible (plastic) increase in β-Gal. Our findings provide a partial explanation for chemoresistance under anchorage-independent conditions and a new target to eliminate highly resistant floating cells. Ultimately, eliminating Q/S floating cells may prevent or reduce metastasis.

Indexed as

beta-GalactosidaseCellular SenescenceNeoplasmsUp-RegulationCell AdhesionCell Line, TumorCell ProliferationEtoposideHumansbeta-GalactosidaseEtoposidegalactoseplasticityquiescencesenescencespheroidsβ-galactosidase

Identifiers

PMID41227313
PMCPMC12609888

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.